Zeolitic Imidazolate Framework-8 (ZIF-8) as a Drug Delivery Vehicle for the Transport and Release of Telomerase Inhibitor BIBR 1532

Telomerase is constitutively overexpressed in the majority of human cancers and telomerase inhibition provides a promising broad-spectrum anticancer therapeutic strategy. BIBR 1532 is a well-known synthetic telomerase inhibitor that blocks the enzymatic activity of hTERT, the catalytic subunit of telomerase. However, water insolubility of BIBR 1532 leads to low cellular uptake and inadequate delivery and thus, limits its anti-tumor effects. Zeolitic imidazolate framework-8 (ZIF-8) is considered as an attractive drug delivery vehicle for improved transport, release and anti-tumor effects of BIBR 1532. Herein, ZIF-8 and BIBR 1532@ZIF-8 were synthesized, respectively, and the physicochemical characterizations confirmed the successful encapsulation of BIBR 1532 in ZIF-8 coupled with an improved stability of BIBR 1532. ZIF-8 could alter the permeability of lysosomal membrane probably by the imidazole ring-dependent protonation. Moreover, ZIF-8 encapsulation facilitated the cellular uptake and release of BIBR 1532 with more accumulation in the nucleus. BIBR 1532 encapsulation with ZIF-8 triggered a more obvious growth inhibition of cancer cells as compared with free BIBR 1532. A more potent inhibition on hTERT mRNA expression, aggravated G0/G1 arrest accompanied with an increased cellular senescence were detected in BIBR 1532@ZIF-8-treated cancer cells. Our work has provided preliminary information on improving the transport, release and efficacy of water-insoluble small molecule drugs by using ZIF-8 as a delivery vehicle.

[1]  L. A. Chiavacci,et al.  ZnO@ZIF-8 Nanoparticles as Nanocarrier of Ciprofloxacin for Antimicrobial Activity , 2023, Pharmaceutics.

[2]  L. Teng,et al.  Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy , 2023, Theranostics.

[3]  Ailing Zhong,et al.  Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment , 2022, Signal transduction and targeted therapy.

[4]  L. Shimon,et al.  Crystallographic–Morphological Connections in Star Shaped Metal–Organic Frameworks , 2022, Journal of the American Chemical Society.

[5]  Mingxuan Ma,et al.  A review on chiral metal-organic frameworks: synthesis and asymmetric applications. , 2022, Nanoscale.

[6]  Vivian V. H. Hook,et al.  Cathepsin B Dipeptidyl Carboxypeptidase and Endopeptidase Activities Demonstrated across a Broad pH Range , 2022, Biochemistry.

[7]  D. Fairen-jimenez,et al.  The uptake of metal–organic frameworks: a journey into the cell , 2022, Chemical Society reviews.

[8]  T. Bendikov,et al.  Directing the Morphology, Packing, and Properties of Chiral Metal–Organic Frameworks by Cation Exchange , 2022, Angewandte Chemie.

[9]  Jiexin Yan,et al.  Construction and evaluation of detachable bone-targeting MOF carriers for the delivery of proteasome inhibitors , 2022, RSC advances.

[10]  W. Gong,et al.  Chiral Metal-Organic Frameworks. , 2022, Chemical reviews.

[11]  M. Ranjbar,et al.  Overexpression of Lysosome-Associated Membrane Protein 1 in Oral Squamous Cell Carcinoma and its Correlation with Tumor Differentiation and Metastasis , 2022, Iranian journal of otorhinolaryngology.

[12]  Fenglei Gao,et al.  Octahedral Pt-MOF with Au deposition for plasmonic effect and Schottky junction enhanced hydrogenothermal therapy of rheumatoid arthritis , 2022, Materials today. Bio.

[13]  S. Ju,et al.  Biodegradable Metal–Organic‐Framework‐Gated Organosilica for Tumor‐Microenvironment‐Unlocked Glutathione‐Depletion‐Enhanced Synergistic Therapy , 2021, Advanced materials.

[14]  Aohua Wang,et al.  Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Jianquan Hou,et al.  Folic Acid–Modified miR-491-5p–Loaded ZIF-8 Nanoparticles Inhibit Castration-Resistant Prostate Cancer by Regulating the Expression of EPHX1 , 2021, Frontiers in Bioengineering and Biotechnology.

[16]  K. Na,et al.  ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin , 2021, Biomaterials Research.

[17]  Yu Chen,et al.  Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy , 2021, Advanced materials.

[18]  S. Ficarro,et al.  BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage , 2021, Nature Communications.

[19]  Ronnie H. Fang,et al.  A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs , 2021, Advanced science.

[20]  X. Nie,et al.  Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus , 2021, Journal of Nanobiotechnology.

[21]  Jun Zhang,et al.  Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[22]  B. Rothen‐Rutishauser,et al.  Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine , 2021, Chemical Society reviews.

[23]  R. Parton,et al.  Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics , 2021, Nature Nanotechnology.

[24]  Y. Hu,et al.  Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance. , 2020, Biomaterials.

[25]  J. Villanueva,et al.  TARGETING TELOMERASE FOR CANCER THERAPY , 2020, Oncogene.

[26]  Xiaolong Liu,et al.  A cancer cell targeted photosensitizer and therapeutic protein co-delivery nanoplatform based on metal-organic framework for enhanced synergistic photodynamic and protein therapy. , 2020, ACS applied materials & interfaces.

[27]  X. Liu,et al.  Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532. , 2020, Bioorganic chemistry.

[28]  J. Rosen,et al.  Non-canonical functions of Telomerase Reverse Transcriptase – Impact on redox homeostasis , 2020, Redox biology.

[29]  Z. Su,et al.  Layer-by-Layer Decorated Nanoscale ZIF-8 with High Curcumin Loading Effectively Inactivates Gram-Negative and Gram-Positive Bacteria. , 2020, ACS applied bio materials.

[30]  Yachao Li,et al.  Tumor‐Oriented Telomerase‐Terminated Nanoplatform as Versatile Strategy for Multidrug Resistance Reversal in Cancer Treatment , 2020, Advanced healthcare materials.

[31]  M. Kruszewski,et al.  Micronucleus Assay: The State of Art, and Future Directions , 2020, International journal of molecular sciences.

[32]  Dimitrios J. Giliopoulos,et al.  Polymer/Metal Organic Framework (MOF) Nanocomposites for Biomedical Applications , 2020, Molecules.

[33]  Ping Wang,et al.  BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition. , 2019, International journal of radiation oncology, biology, physics.

[34]  Bingjun Sun,et al.  Efficient Intestinal Digestion and On Site Tumor‐Bioactivation are the Two Important Determinants for Chylomicron‐Mediated Lymph‐Targeting Triglyceride‐Mimetic Docetaxel Oral Prodrugs , 2019, Advanced science.

[35]  Joseph J. Richardson,et al.  Metal-Phenolic Coatings as a Platform to Trigger Endosomal Escape of Nanoparticles. , 2019, ACS nano.

[36]  Yan Liu,et al.  Proteasome Inhibition Activates Autophagy-Lysosome Pathway Associated With TFEB Dephosphorylation and Nuclear Translocation , 2019, Front. Cell Dev. Biol..

[37]  Yinsong Wang,et al.  Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death , 2019, Cell Death and Disease.

[38]  Z. Tang,et al.  Encapsulation of Plasmid DNA by Nanoscale Metal–Organic Frameworks for Efficient Gene Transportation and Expression , 2019, Advanced materials.

[39]  S. Wilhelm,et al.  Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. , 2019, Advanced drug delivery reviews.

[40]  Alessandro Bertucci,et al.  Super-resolution Imaging of Proton Sponge-Triggered Rupture of Endosomes and Cytosolic Release of Small Interfering RNA. , 2019, ACS nano.

[41]  M. Venkataswamy,et al.  Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells , 2018, Cytotechnology.

[42]  U. Tabori,et al.  Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer , 2018, Journal of biomedical science.

[43]  Fajr A. Aleisa,et al.  Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework. , 2018, Journal of the American Chemical Society.

[44]  C. Azzalin,et al.  TRF1 participates in chromosome end protection by averting TRF2-dependent telomeric R-loops , 2017, Nature Structural & Molecular Biology.

[45]  Peter K. N. Yu,et al.  Size Controllable and Surface Tunable Zeolitic Imidazolate Framework-8-Poly(acrylic acid sodium salt) Nanocomposites for pH Responsive Drug Release and Enhanced in Vivo Cancer Treatment. , 2017, ACS applied materials & interfaces.

[46]  D. Gomez,et al.  Telomerase as a Cancer Target. Development of New Molecules , 2016, Current topics in medicinal chemistry.

[47]  Long Jiang,et al.  Facile synthesis of enzyme-embedded magnetic metal-organic frameworks as a reusable mimic multi-enzyme system: mimetic peroxidase properties and colorimetric sensor. , 2015, Nanoscale.

[48]  E. Skordalakes,et al.  Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532. , 2015, Structure.

[49]  Christian J. Doonan,et al.  Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules , 2015, Nature Communications.

[50]  Wanguo Wei,et al.  A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines , 2015, Targeted Oncology.

[51]  J. Lorenzo,et al.  Carboxyl group (-CO2 H) functionalized coordination polymer nanoparticles as efficient platforms for drug delivery. , 2014, Chemistry.

[52]  Manuel Serrano,et al.  Cellular senescence: from physiology to pathology , 2014, Nature Reviews Molecular Cell Biology.

[53]  L. Chou,et al.  Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation. , 2014, ACS nano.

[54]  Koji Kida,et al.  Size-controlled Synthesis of Zeolitic Imidazolate Framework-8 (ZIF-8) Crystals in an Aqueous System at Room Temperature , 2012 .

[55]  A. Grach.  Alternative telomere-lengthening mechanisms , 2011, Cytology and Genetics.

[56]  Z. Lai,et al.  Rapid synthesis of zeolitic imidazolate framework-8 (ZIF-8) nanocrystals in an aqueous system. , 2011, Chemical communications.

[57]  M. Hande,et al.  Inhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instability , 2010, Genome Integrity.

[58]  R. Reddel,et al.  Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.

[59]  C. Moreira,et al.  Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone. , 2009, Acta biomaterialia.

[60]  C. Autexier,et al.  Harnessing telomerase in cancer therapeutics. , 2007, Anti-cancer agents in medicinal chemistry.

[61]  E. Eskelinen.  Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. , 2006, Molecular aspects of medicine.

[62]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[63]  U. Martens,et al.  Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. , 2005, Blood.

[64]  T. Tauchi,et al.  Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy , 2003, Leukemia.

[65]  J. Wysocki,et al.  Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients , 2003, European journal of gastroenterology & hepatology.

[66]  A. Schnapp,et al.  Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate* , 2002, The Journal of Biological Chemistry.

[67]  A. Schnapp,et al.  A highly selective telomerase inhibitor limiting human cancer cell proliferation , 2001, The EMBO journal.

[68]  W. Hahn,et al.  Telomerase activation, cellular immortalization and cancer , 2001, Annals of medicine.

[69]  M. Aoe,et al.  Telomerase activity and Bcl-2 expression in non-small cell lung cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  M. Daidone,et al.  Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents. , 2000, International journal of oncology.

[71]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[72]  R. Parwaresch,et al.  Telomerase, immortality and cancer. , 2000, Biotechnology annual review.

[73]  V. Garaj-Vrhovac,et al.  Induction of micronuclei in human lymphocytes after occupational exposure to ultrasound. , 1999, Chemosphere.

[74]  H Anholt,et al.  Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.

[75]  H. Norppa,et al.  Micronuclei induced by alachlor, mitomycin-C and vinblastine in human lymphocytes: presence of centromeres and kinetochores and influence of staining technique. , 1995, Mutagenesis.

[76]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[77]  J. Skehel,et al.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. , 1987, Annual review of biochemistry.

[78]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.